Lyon, France

Laurence De La Fourniere

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Mallinckrodt, Inc.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurence De La Fourniere. Retrieved from https://idiyas.com/inventor/laurence-de-la-fourniere

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Laurence De La Fourniere

Introduction

Laurence De La Fourniere is a notable inventor based in Lyons, France. He has made significant contributions to the field of radiopharmaceuticals, particularly in the stabilization of peptides and proteins. His work is essential for enhancing the efficacy of diagnostic and therapeutic applications in medicine.

Latest Patents

De La Fourniere holds a patent for the "Stabilization of peptides and proteins for radiopharmaceutical use." This innovative patent utilizes surfactants, either alone or in combination with salts, to stabilize radiolabeled peptides and proteins. This advancement is crucial for improving the performance of radiopharmaceutical compositions used in medical diagnostics and treatments. He has 1 patent to his name.

Career Highlights

Laurence De La Fourniere is currently employed at Mallinckrodt, Inc., a company known for its focus on specialty pharmaceuticals. His role at the company allows him to apply his expertise in radiopharmaceuticals and contribute to the development of innovative medical solutions.

Collaborations

One of his notable collaborators is Kathleen M Miller. Their partnership exemplifies the collaborative spirit in the field of scientific research and innovation.

Conclusion

Laurence De La Fourniere's contributions to the field of radiopharmaceuticals through his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the effectiveness of diagnostic and therapeutic applications in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…